Clinical Review Science, medicine, and the future

Tolerance and autoimmunity

BMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7253.93 (Published 08 July 2000) Cite this as: BMJ 2000;321:93
  1. Ian R Mackay, honorary professorial fellow (ian.mackay@med.monash.edu.au)
  1. Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3168, Australia

    Immune tolerance and autoimmunity are important clinically. Firstly, there are at least 40 known or suspected autoimmune diseases, and many are common (see box). Overall, 1 person in 31 is affected.1 Moreover, autoimmune type 1 diabetes is the most common of all chronic diseases of children. Secondly, autoimmune disease is poorly diagnosed because the onset can be stealthy, and initial symptoms are often non-specific—tiredness, fatigue, or fever. Thirdly, patients with autoimmune disease will expect an interpretation of their illness from their doctor. Fourthly, new insights are set to revolutionise management, by replacement of blanket immunosuppression with new selective immunotherapies

    Prevalence of autoimmune diseases

    • Thyroid diseases (includes Hashimoto's thyroiditis and Graves' disease): >3% of adult women

    • Rheumatoid arthritis: 1% of general population, but female excess

    • Primary Sjögren's syndrome: 0.6-3% of adult women

    • Systemic lupus erythematosus: 0.12% of general population, but female excess

    • Multiple sclerosis: 0.1% of general population, but female excess

    • Type 1 diabetes: 0.1% of children

    • Primary biliary cirrhosis: 0.05-0.1% of middle aged and elderly women

    • Myasthenia gravis: 0.01% of general population, but female excess

    Immune tolerance and the immune response

    Figure 1 illustrates how tolerance is established and maintained and how it fails with ensuing autoimmunity. Specific immune and autoimmune responses involve the same elements. These include (a) an antigen (or autoantigen); (b) a response by interacting families and subsets of cells that include antigen presenting cells, T lymphocytes, and B lymphocytes; (c) messenger molecules, cytokines, chemokines, and their receptors; and (d) signalling and costimulatory molecules on cell surfaces (fig 2). Many of the functionally important cell surface molecules and their receptors are described by the cluster of differentiation (CD) nomenclature, based on their identification by characterised monoclonal antibodies.

    Predicted developments

    Closer insights into generation of natural immune tolerance to self

    Clarification of importance of apoptosis for loss of tolerance and development of autoimmunity

    Enhanced understanding of how the “wrong …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe